Introduction: Salivary duct carcinoma is one of the rarest and most aggressive forms of parotid tumor. We report two cases. Cases: Case 1: a 78-year-old man was referred for a salivary duct carcinoma of the left parotid gland. Treatment was surgical (parotidectomy with ipsilateral selective neck dissection), without capsule rupture, and with healthy margins. At seven years' follow-up, the patient was alive and disease-free.
Introduction
Salivary duct carcinoma was first described in 1968 [1] . It is an aggressive adenocarcinoma, resembling a high-grade mammary duct carcinoma. Salivary gland sites are rare for this epithelial tumor [2] [3] [4] .
Two cases are reported and discussed in the light of the literature.
Case 1
A 78-year-old man was referred for painful swelling of the left parotid region. On examination, the swelling was firm, mobile and non-fixed. The patient showed House grade III facial palsy. The lymph node areas were free. On CT, the tumefaction in the exofacial part of the parotid gland, measuring about 18 mm, with fuzzy contour, showed moderate contrast-medium uptake. Treatment comprised parotidectomy, not conserving the facial nerve (which was invaded), with selective ipsilateral lymph node curage (as extemporaneous histology suggested a malignant etiology). The definitive histological examination diagnosed salivary duct carcinoma with exeresis margins exceeding 1 cm but with perineural sheathing. The lymph node specimens were healthy. There was no vascular embolism. The resection margins were healthy; no adjuvant treatment was prescribed. At seven years' follow-up, the patient was alive and without recurrence.
Case 2
A 41-year-old man was referred with two years' history of left parotid tumefaction. On examination, the tumefaction was hard, with little mobility. Facial function was normal. The lymph node areas were free. MRI ( Fig. 1) showed a multinodular exofacial parotid tumor of about 5 cm, in T1 isosignal with peripheral gadolinium enhancement and T2 hypersignal. Treatment was surgical (total parotidectomy conserving the facial nerve, with modified ipsilateral radical cervical curage as extemporaneous examination suggested a malignant etiology). Definitive histological examination diagnosed salivary duct carcinoma without lymphatic embolism or perineural sheathing. The lymph node specimens were healthy. The resection margins were healthy but less than 1 cm (and even less than 5 mm on certain slices); postoperative radiation therapy (70 Gy) was therefore undertaken. At eight years' follow-up, the patient was alive and free of recurrence.
Discussion
Salivary duct carcinoma represents 0.2% to 2% of parotid tumors [2] , and 6% to 10% of parotid cancers [3] . Onset is generally in the fifth or sixth decade of life, for a mean age of 60 years [3] . It mainly affects men, with a male-to-female sex-ratio of 2:1. In some 20% of cases, it develops from a Figure 2 Anatomopathology slide of first case specimen (HES staining) (×100). This was a tumor formed of oncocytic cells with eosinophilic cytoplasm and nucleolated nuclei. Some mitoses were observed. The center of the duct was necrotic in this case, giving a so-called comedo aspect.
pre-existing benign lesion; it may, for example, result from degeneration of a pleomorphic adenoma [3, 4] .
Macroscopically, the aspect is of a well-contoured yellowish or grayish-white tumor that may be nodular, multinodular, cystic or infiltrating, surrounded by fibrosis with hemorrhagic areas, necrosis and cystic degeneration [3] . There may be intratumoral calcification [3, 5] . The most frequent histologic forms are comedonecrotic (Fig. 2) , papillary or cribriform (Fig. 3) [4, 6] . There is also intraduct cellular proliferation with eosinophilic cytoplasm nuclear polymorphism showing some mitoses and an elevated nuclear-cytoplasmic ratio [3] . Differential diagnoses comprise mucoepidermoid carcinoma and mammary adenocarcinoma metastasis. In case of doubt, studying estrogen and progesterone receptors and immunohistochemical exploration for HER-2 protein may be contributive [7] .
The most common clinical aspect is parotid tumefaction which rapidly becomes progressive and is usually painful [3] , Figure 3 Anatomopathology slide of first case specimen (HES staining) (×100). Typical cribriform disposition of a salivary duct carcinoma.
hard on palpation, measuring about 3 cm and possibly reaching 9 to 10 cm at diagnosis [6] . Facial palsy, expressing the local aggressiveness of the tumor, is found in almost half of cases at diagnosis [6] . Lymph node invasion is also found in 40% to 80% of cases [4] .
Radiologically, calcification may be found in the primitive lesion [3] . MRI finds a uni or multinodular tumor in T1 isosignal and T2 isosignal, strongly enhanced by gadolinium (Fig. 1) .
The invasive nature of salivary duct carcinoma requires radical treatment. This is based on surgical removal by total parotidectomy with or without conservation of the facial nerve, depending on its involvement, associated to ipsilateral lymph node curage. The rate of locoregional failure is high [4] . Invaded or insufficient resection margins, lymphatic embolism, perineural invasion, extraparotid and/or lymphatic invasion, local and/or regional recurrence and metastasis are factors of poor prognosis for survival [4, [8] [9] [10] , and in these cases postoperative radiation therapy is mandatory. Chemotherapy is generally reserved for metastatic forms. Prognosis is better in tumors measuring less than 2 cm [4, 8] . Five-year recurrence-free survivorship is about 30% [2, 6] .
Conclusion
Salivary duct carcinoma is an aggressive malignant tumor for which treatment is essentially surgical. Adjuvant radiation therapy is reserved to evolved forms.
